Variant report

Variant	esv3410331
Chromosome Location	chr19:39055137-39057160
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:73)
CpG islands
(count:305)
Chromatin interactive
region (count:1)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:73 , 50 per page) page: 1 2

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BHLHE40	chr19:39055794-39056024	GM12878	blood:	n/a	n/a
2	BHLHE40	chr19:39056316-39056364	GM12878	blood:	n/a	n/a
3	CREB1	chr19:39055735-39056375	A549	lung:	n/a	n/a
4	CTCF	chr19:39056080-39056230	GM12866	blood:	n/a	n/a
5	CTCF	chr19:39056048-39056323	GM19239	blood:	n/a	n/a
6	CTCF	chr19:39055480-39055630	GM12871	blood:	n/a	n/a
7	CTCF	chr19:39055999-39056000	GM19239	blood:	n/a	n/a
8	CTCF	chr19:39056128-39056282	GM12892	blood:	n/a	n/a
9	CTCF	chr19:39055917-39055983	NHEK	skin:	n/a	n/a
10	CTCF	chr19:39056160-39056310	GM12865	blood:	n/a	n/a
11	CTCF	chr19:39056209-39056221	GM12878	blood:	n/a	n/a
12	CTCF	chr19:39056040-39056045	GM19239	blood:	n/a	n/a
13	CTCF	chr19:39056197-39056281	GM19238	blood:	n/a	n/a
14	CTCF	chr19:39055939-39056015	MCF-7	breast:	n/a	n/a
15	CTCF	chr19:39056167-39056277	GM19240	blood:	n/a	n/a
16	CTCF	chr19:39056060-39056210	GM12873	blood:	n/a	n/a
17	CTCF	chr19:39055320-39055470	GM12871	blood:	n/a	n/a
18	CTCF	chr19:39055420-39055570	SK-N-SH_RA	brain:	n/a	n/a
19	CTCF	chr19:39056100-39056250	GM12875	blood:	n/a	n/a
20	CTCF	chr19:39055960-39055980	GM19239	blood:	n/a	n/a
21	CTCF	chr19:39056090-39056268	GM12878	blood:	n/a	n/a
22	CTCF	chr19:39055880-39056030	GM12866	blood:	n/a	n/a
23	CTCF	chr19:39056200-39056350	GM12874	blood:	n/a	n/a
24	CTCF	chr19:39056111-39056300	NHEK	skin:	n/a	n/a
25	CTCF	chr19:39056198-39056201	GM12878	blood:	n/a	n/a
26	CTCF	chr19:39055958-39056005	GM12891	blood:	n/a	n/a
27	CTCF	chr19:39056112-39056287	GM12891	blood:	n/a	n/a
28	CTCF	chr19:39055913-39056019	MCF-7	breast:	n/a	n/a
29	E2F6	chr19:39055383-39056571	A549	lung:	n/a	n/a
30	E2F6	chr19:39055964-39056458	A549	lung:	n/a	n/a
31	EBF1	chr19:39055751-39056344	GM12878	blood:	n/a	n/a
32	EGR1	chr19:39056260-39056448	GM12878	blood:	n/a	chr19:39056363-39056377
33	EGR1	chr19:39055941-39056074	GM12878	blood:	n/a	chr19:39056014-39056028
34	EGR1	chr19:39055863-39056121	GM12878	blood:	n/a	chr19:39056014-39056028
35	ELF1	chr19:39056036-39056567	GM12878	blood:	n/a	n/a
36	ELK1	chr19:39056280-39056433	GM12878	blood:	n/a	n/a
37	EP300	chr19:39056366-39056374	GM12878	blood:	n/a	n/a
38	GATA2	chr19:39055549-39055794	SH-SY5Y	brain:	n/a	n/a
39	MAX	chr19:39055337-39056694	A549	lung:	n/a	n/a
40	MAX	chr19:39055841-39056556	HCT-116	colon:	n/a	n/a
41	MAX	chr19:39055394-39056575	A549	lung:	n/a	n/a
42	MAX	chr19:39055563-39056424	ECC-1	luminal epithelium:	n/a	n/a
43	MAX	chr19:39056001-39056467	ECC-1	luminal epithelium:	n/a	n/a
44	MAX	chr19:39055996-39056393	H1-hESC	embryonic stem cell:	n/a	n/a
45	MAX	chr19:39056037-39056483	GM12878	blood:	n/a	n/a
46	MAX	chr19:39055844-39056490	HCT-116	colon:	n/a	n/a
47	MAX	chr19:39056016-39056429	H1-hESC	embryonic stem cell:	n/a	n/a
48	MAX	chr19:39056062-39056347	A549	lung:	n/a	n/a
49	MAZ	chr19:39056286-39056409	GM12878	blood:	n/a	n/a
50	MYC	chr19:39056167-39056206	GM12878	blood:	n/a	n/a

(count:305 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr19:39056126-39056176	Hela-S3	cervix:	n/a
2	chr19:39055500-39055550	Caco-2	colon:	n/a
3	chr19:39056216-39056266	HepG2	liver:	n/a
4	chr19:39055712-39055762	RPTEC	kidney:	n/a
5	chr19:39056216-39056266	BJ	skin:	n/a
6	chr19:39055500-39055550	AG10803	skin:	n/a
7	chr19:39056084-39056134	HRE	kidney:	n/a
8	chr19:39056126-39056176	AG10803	skin:	n/a
9	chr19:39056126-39056176	GM12891	blood:	n/a
10	chr19:39055500-39055550	GM12891	blood:	n/a
11	chr19:39055712-39055762	PANC-1	pancreas:	n/a
12	chr19:39056126-39056176	Jurkat	blood:	n/a
13	chr19:39056126-39056176	AG09319	gingival:	n/a
14	chr19:39056126-39056176	PANC-1	pancreas:	n/a
15	chr19:39055500-39055550	BJ	skin:	n/a
16	chr19:39055500-39055550	GM12892	blood:	n/a
17	chr19:39056084-39056134	HL-60	blood:	n/a
18	chr19:39056084-39056134	H1-hESC	embryonic stem cell:	embryo
19	chr19:39056084-39056134	IMR90	lung:	fetal
20	chr19:39056126-39056176	CMK	blood:	n/a
21	chr19:39055500-39055550	AG09309	skin:	n/a
22	chr19:39056216-39056266	HPAEpiC	pulmonary alveolar:	n/a
23	chr19:39056216-39056266	Jurkat	blood:	n/a
24	chr19:39056126-39056176	HNPCEpiC	eye:	n/a
25	chr19:39055712-39055762	BE2_C	brain:	n/a
26	chr19:39055712-39055762	HMEC	breast:	n/a
27	chr19:39055500-39055550	PANC-1	pancreas:	n/a
28	chr19:39055500-39055550	HCF	heart:	n/a
29	chr19:39055712-39055762	BJ	skin:	n/a
30	chr19:39056126-39056176	HepG2	liver:	n/a
31	chr19:39056084-39056134	HUVEC	blood vessel:	n/a
32	chr19:39056216-39056266	U87	brain:	n/a
33	chr19:39055500-39055550	NHDF-neo	bronchial:	n/a
34	chr19:39056216-39056266	AG04449	skin:	fetal
35	chr19:39056216-39056266	ECC-1	luminal epithelium:	n/a
36	chr19:39055500-39055550	Hela-S3	cervix:	n/a
37	chr19:39055712-39055762	HIPEpiC	eye:	n/a
38	chr19:39056126-39056176	H1-hESC	embryonic stem cell:	embryo
39	chr19:39055712-39055762	HRPEpiC	eye:	n/a
40	chr19:39056216-39056266	IMR90	lung:	fetal
41	chr19:39056126-39056176	Caco-2	colon:	n/a
42	chr19:39055500-39055550	NT2-D1	testis:	n/a
43	chr19:39056216-39056266	ovcar-3	ovarian:	n/a
44	chr19:39056084-39056134	GM12878	blood:	n/a
45	chr19:39056084-39056134	HEEpiC	esophagus:	n/a
46	chr19:39055500-39055550	HL-60	blood:	n/a
47	chr19:39056084-39056134	BJ	skin:	n/a
48	chr19:39056216-39056266	SK-N-SH_RA	brain:	n/a
49	chr19:39056084-39056134	HepG2	liver:	n/a
50	chr19:39056126-39056176	GM12878	blood:	n/a

(count:1 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr19:39054660..39056810-chr19:39061763..39063298,2	K562	blood:

No data

Variant related genes	Relation type
RYR1	TF binding region
RYR1	CpG island

Extended variants
information (count: 99 )
Associated
traits (count: 66 )

Variant overlapped rSNPs/rCNVs (count:99 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs113183691	chr19:39055151-39055152	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
2	rs549017169	chr19:39055154-39055155	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
3	rs369508072	chr19:39055173-39055174	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
4	rs552070376	chr19:39055175-39055176	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
5	rs192628584	chr19:39055211-39055212	Weak transcription Strong transcription Flanking Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
6	rs538510507	chr19:39055220-39055221	Weak transcription Strong transcription Flanking Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
7	rs570295848	chr19:39055243-39055244	Weak transcription Strong transcription Flanking Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
8	rs375507910	chr19:39055251-39055252	Weak transcription Strong transcription Flanking Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
9	rs370361438	chr19:39055272-39055273	Weak transcription Strong transcription Flanking Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
10	rs10415792	chr19:39055304-39055305	Weak transcription Strong transcription Flanking Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
11	rs373422923	chr19:39055321-39055322	Weak transcription Strong transcription Flanking Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs553802323	chr19:39055338-39055339	Weak transcription Strong transcription Flanking Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs10415812	chr19:39055343-39055344	Weak transcription Strong transcription Flanking Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
14	rs200893673	chr19:39055352-39055353	Weak transcription Strong transcription Flanking Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs542577636	chr19:39055358-39055359	Weak transcription Strong transcription Flanking Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs141858105	chr19:39055361-39055362	Weak transcription Strong transcription Flanking Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs71165562	chr19:39055407-39055408	Weak transcription Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs146260773	chr19:39055412-39055413	Weak transcription Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs139136652	chr19:39055436-39055437	Weak transcription Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs573087940	chr19:39055447-39055448	Weak transcription Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs533105783	chr19:39055459-39055460	Weak transcription Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs551310799	chr19:39055508-39055509	Weak transcription Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Strong transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
23	rs560257699	chr19:39055545-39055546	Weak transcription Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Strong transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
24	rs376492480	chr19:39055565-39055566	Weak transcription Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs138932463	chr19:39055603-39055604	Weak transcription Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs118192165	chr19:39055614-39055615	Weak transcription Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs370527763	chr19:39055615-39055616	Weak transcription Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs549127909	chr19:39055635-39055636	Weak transcription Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs141678912	chr19:39055646-39055647	Weak transcription Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs193922852	chr19:39055674-39055675	Weak transcription Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs80039127	chr19:39055715-39055716	Weak transcription Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Strong transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
32	rs113553675	chr19:39055724-39055725	Weak transcription Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Strong transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
33	rs372770916	chr19:39055760-39055761	Weak transcription Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Strong transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
34	rs201315104	chr19:39055774-39055775	Weak transcription Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs193922853	chr19:39055822-39055823	Weak transcription Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Enhancers Bivalent Enhancer Flanking Active TSS Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs566468513	chr19:39055825-39055826	Weak transcription Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Enhancers Bivalent Enhancer Flanking Active TSS Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs531248900	chr19:39055837-39055838	Weak transcription Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Enhancers Bivalent Enhancer Flanking Active TSS Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs398123469	chr19:39055843-39055844	Weak transcription Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Enhancers Bivalent Enhancer Flanking Active TSS Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs193922854	chr19:39055853-39055854	Weak transcription Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Enhancers Bivalent Enhancer Flanking Active TSS Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs193922855	chr19:39055858-39055859	Weak transcription Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Enhancers Bivalent Enhancer Flanking Active TSS Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs571850239	chr19:39055862-39055863	Weak transcription Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Enhancers Bivalent Enhancer Flanking Active TSS Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs575192320	chr19:39055904-39055905	Weak transcription Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Enhancers Bivalent Enhancer Flanking Active TSS Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs539194350	chr19:39055930-39055931	Weak transcription Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Enhancers Bivalent Enhancer Flanking Active TSS Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs193922846	chr19:39055942-39055943	Weak transcription Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Enhancers Bivalent Enhancer Flanking Active TSS Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs118192129	chr19:39055960-39055961	Weak transcription Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Enhancers Bivalent Enhancer Flanking Active TSS Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs184450380	chr19:39055964-39055965	Weak transcription Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Enhancers Bivalent Enhancer Flanking Active TSS Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs193922856	chr19:39055987-39055988	Weak transcription Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Enhancers Bivalent Enhancer Flanking Active TSS Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs12981200	chr19:39056007-39056008	Weak transcription Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs565965327	chr19:39056032-39056033	Weak transcription Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs112906851	chr19:39056033-39056034	Weak transcription Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:66)

Disease	PMID	Source
Myelodysplastic syndrome	17634407	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Ovarian cancer	21720365	CNVD
Cancer	20164919	CNVD
Thoracic aortic aneurysm	21092924	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Prostate cancer	18632612	CNVD
Autism	22495311	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Ductal carcinoma	22052326	CNVD
Pleomorphic liposarcoma	18784837	CNVD
Congenital nephrotic syndrome	18421352	CNVD
Astrocytoma	17934521	CNVD
Leukemia	17361228	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Breast cancer	21858162	CNVD
Breast cancer	17603634	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Oligodendroglial tumors	17285580	CNVD
renal disease	20603712	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Disorders of sex development	21048976	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	21364760	CNVD
Invasive pancreatic ductal carcinoma	18765526	CNVD
Rhabdomyosarcoma	16790082	CNVD
Chordoma	18071362	CNVD
Urothelial carcinoma	21177765	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Wilms tumour	21544195	CNVD
Mental retardation	19951919	CNVD
19q13.11 deletion syndrome	22378287	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	21045282	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Ovarian neoplasms	16753589	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Metanephric adenoma	20802469	CNVD
Acute myeloid leukemia	16864856	CNVD
Lung cancer	21569311	CNVD
Bladder cancer	21909424	CNVD
Medulloblastoma	16783165	CNVD
Breast cancer	21509527	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Gastric cancer	18160780	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	19029149	CNVD
Breast cancer	20409316	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Multiple myeloma	16616336	CNVD
Renal cell carcinoma	18765545	CNVD
Acute myeloid leukemia	20729466	CNVD

Chromatin state (count:203 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:38985200-39081800	Weak transcription	Psoas Muscle	Psoas
2	chr19:39030200-39055200	Weak transcription	iPS-20b Cell Line	embryonic stem cell
3	chr19:39035200-39066400	Strong transcription	Skeletal Muscle Male	skeletal muscle
4	chr19:39036000-39076400	Weak transcription	Brain Substantia Nigra	brain
5	chr19:39045000-39055600	Weak transcription	Right Atrium	heart
6	chr19:39050800-39055400	Weak transcription	A549	lung
7	chr19:39051000-39056200	Weak transcription	Primary T helper naive cells from peripheral blood	blood
8	chr19:39051200-39055400	Weak transcription	Primary T cells effector/memory enriched fromperipheralblood	blood
9	chr19:39051200-39055600	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
10	chr19:39051600-39066400	Strong transcription	Skeletal Muscle Female	skeletal muscle
11	chr19:39051800-39055400	Strong transcription	H9 Cell Line	embryonic stem cell
12	chr19:39051800-39055400	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
13	chr19:39051800-39056200	Weak transcription	Primary T killer memory cells from peripheral blood	blood
14	chr19:39051800-39056400	Weak transcription	Primary T helper memory cells from peripheral blood 2	blood
15	chr19:39052000-39055200	Weak transcription	Primary T helper 17 cells PMA-I stimulated	--
16	chr19:39052000-39055400	Weak transcription	Primary T regulatory cells fromperipheralblood	blood
17	chr19:39052200-39055200	Weak transcription	Primary T helper memory cells from peripheral blood 1	blood
18	chr19:39052800-39055200	Weak transcription	HUES6 Cell Line	embryonic stem cell
19	chr19:39052800-39055600	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
20	chr19:39053200-39077800	Weak transcription	Brain Hippocampus Middle	brain
21	chr19:39053200-39086800	Weak transcription	Brain Angular Gyrus	brain
22	chr19:39053200-39086800	Weak transcription	Brain Inferior Temporal Lobe	brain
23	chr19:39053400-39055600	Weak transcription	Spleen	Spleen
24	chr19:39053400-39075400	Weak transcription	Brain Anterior Caudate	brain
25	chr19:39053600-39055600	Weak transcription	Gastric	stomach
26	chr19:39053800-39055200	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
27	chr19:39053800-39055400	Weak transcription	H1 Cell Line	embryonic stem cell
28	chr19:39053800-39055400	Weak transcription	Esophagus	oesophagus
29	chr19:39053800-39055400	Weak transcription	GM12878-XiMat	blood
30	chr19:39053800-39056000	Weak transcription	Brain Cingulate Gyrus	brain
31	chr19:39053800-39061400	Weak transcription	Brain Dorsolateral Prefrontal Cortex	brain
32	chr19:39054000-39055200	Weak transcription	iPS-18 Cell Line	embryonic stem cell
33	chr19:39054000-39055200	Weak transcription	Primary T killer naive cells fromperipheralblood	blood
34	chr19:39054400-39055200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
35	chr19:39054400-39055400	Enhancers	Breast Myoepithelial Primary Cells	Breast
36	chr19:39055000-39056000	Bivalent Enhancer	Fetal Muscle Trunk	muscle
37	chr19:39055000-39056800	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
38	chr19:39055000-39057200	Weak transcription	HSMMtube	muscle
39	chr19:39055200-39055400	Flanking Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
40	chr19:39055200-39055400	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
41	chr19:39055200-39055400	Bivalent Enhancer	Fetal Intestine Small	intestine
42	chr19:39055200-39055600	Bivalent Enhancer	ES-UCSF4 Cell Line	embryonic stem cell
43	chr19:39055200-39055600	Bivalent Enhancer	Primary T helper cells PMA-I stimulated	--
44	chr19:39055200-39055600	Bivalent Enhancer	Fetal Intestine Large	intestine
45	chr19:39055200-39055600	Flanking Bivalent TSS/Enh	Monocytes-CD14+_RO01746	blood
46	chr19:39055200-39055800	Bivalent Enhancer	Primary monocytes fromperipheralblood	blood
47	chr19:39055200-39055800	Bivalent Enhancer	Primary B cells from peripheral blood	blood
48	chr19:39055200-39056000	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
49	chr19:39055400-39055600	Bivalent Enhancer	Primary B cells from cord blood	blood
50	chr19:39055400-39055600	Flanking Active TSS	Primary T helper 17 cells PMA-I stimulated	--

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links